Pract Radiat Oncol 2022 Sep-Oct
Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline.
Related Questions
How does 1p/19q co-deletion and IDH mutation status influence your decision?
New answer by Radiation Oncologist at Turville Bay MRI & Radiation Oncology Center (March 15, 2023)
Yes. We should be humble about the data supporting RT in this scenario (that is, for IDH-mutant tumors). I would suggest that for IDH wild-type tumors (i.e., molecular GB...